Consultation skills - Consultations with anxious patients
Empathy and reassurance can help in consultations with anxious patients, explains Dr Mona Kular. Read more
The long-acting anticholinergic drug, marketed as Spiriva, reduced exacerbations, delayed time to first exacerbation and cut the risk of exacerbations leading to hospital admission.
However, it failed to statistically significantly reduce decline in FEV1 after four years, the trial's primary endpoint.
The finding of reduced mortality contrasts with a recent JAMA analysis suggesting anticholinergics raise CVD risk.
Comment below and tell us what you think
Quick search - use * for an abbreviated search, eg nico*
Empathy and reassurance can help in consultations with anxious patients, explains Dr Mona Kular. Read more
Medico-legal adviser Dr Jim Rodger offers some expert advice on how to excel as a GP registrar. Read more
Dr Kingsley Poole describes the differences he experienced working at a remote practice in New Zeala... Read more
Contributed by Dr Charlie Easmon specialist adviser in travel medicine and medical director at The N... Read more
Contributed by Mr Ranan DasGupta, specialist registrar and Mr Jonathon Olsburgh, consultant urologic... Read more
By Dr Helen Hosker, GP and clinical commissioning lead for stroke, NHS Manchester, and Dr Pippa Tyrr... Read more
Leo Pharma has launched Xamiol gel, a combination of calcipotriol + betamethasone, for the treatment... Read more
Bayer HealthCare has launched Xarelto (rivaroxaban) for the prevention of venous thromboembolism in ... Read more
Wyeth has launched Torisel (temsirolimus), a first-line treatment for advanced renal cell carcinoma ... Read more
Comments
Only registered users may comment. Log in now or register for a free account.